PrisMax V3
Closed Special Notice Posted
- Solicitation number
- 26-008236
- Agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health Office of Logistics and Acquisition Operations is announcing a sole-source procurement for one PrisMax V3 Continuous Renal Replacement Therapy machine, one TherMax Blood Warmer accessory, and one PrisMax Warmer Arm Kit totaling $32,868.25, with a response deadline of September 26, 2026. Vantive holds exclusive rights to the PrisMax CRRT system; no competing equipment provides equivalent capabilities for the specified therapies (CVVHDF, CVVHD, CVVH, SCUF). The equipment will support the NIH Clinical Center's newly established Pediatric Intensive Care Unit and serves patients weighing 20 kilograms or more with acute renal failure, fluid overload, or conditions requiring plasma component removal and therapeutic plasma exchange. The Clinical Center has integrated five existing PrisMax units with its EHR system (CRIS) since 2020; procurement of an identical sixth unit maintains protocol consistency, ensures patient safety, and avoids operational, IT, cybersecurity, training, and labor costs associated with introducing incompatible equipment. Market research included ECRI equipment comparison reports and consultation with the Clinical Center's Standardization Committee. The procurement falls within the simplified acquisition threshold.
Notice text
With the establishment of the new Pediatric Intensive Care Unit (PICU), the CC needs to add one PrisMax Continuous Renal Replacement Therapy (CRRT) machine to their existing fleet of 5 Prismax CRRT. The CC successfully integrated the PrisMax with the hospital’s EHR, CRIS in 2020.
PrisMax Systems are intended for:
- Continuous Renal Replacement Therapy (CRRT) for patients weighing 20 kilograms or more with acute renal failure and/or fluid overload.
- Therapeutic Plasma Exchange (TPE) therapy for patients weighing 20 kilograms or more with diseases where fluid removal of plasma components is indicated.
- The TherMax Blood Warmer Accessory is indicated for warming returning blood flow.
DESCRIPTION OF THE SUPPLIES AND SERVICES REQUIRED, INCLUDING THE DELIVERY SCHEDULE AND/OR THE PERIOD OF PERFORMANCE and DOLLAR VALUE OF THE ACQUISITON.
Procurement is for:
- One (1) PrisMax V3 US
- One (1) TherMax Blood Warmer
- One (1) PrisMax Warmer Arm Kit
Files
| File | Type | Posted |
|---|---|---|
| 26-008236 - Sole Source Justification.docx | DOCX document |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity